Teva
Teva Pharmaceutical Industries Ltd., commonly known as Teva, is a global leader in the pharmaceutical industry, headquartered in Petah Tikva, Israel, with significant operations in North America and Europe. Founded in 1901, Teva has established itself as a key player in generic and specialty medicines, focusing on therapeutic areas such as central nervous system disorders, oncology, and respiratory conditions. Teva's extensive portfolio includes a wide range of generic drugs, biosimilars, and innovative specialty treatments, distinguished by their commitment to quality and accessibility. The company has achieved notable milestones, including the launch of the first generic version of Copaxone, a breakthrough treatment for multiple sclerosis. With a strong market position, Teva continues to drive advancements in healthcare, making a significant impact on patient lives worldwide.
DitchCarbon Score
How does Teva's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Teva's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Teva's reported carbon emissions
Teva Pharmaceuticals, headquartered in "NE", currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their total emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of detailed emissions data, it is important to note that Teva has made commitments to address climate change and reduce its environmental impact. However, specific reduction targets or initiatives have not been disclosed. This lack of information highlights a broader context within the pharmaceutical industry, where companies are increasingly being called upon to enhance transparency regarding their carbon footprints and climate strategies. As the industry evolves, stakeholders are encouraged to monitor Teva's future announcements regarding their climate commitments and any potential emissions reduction targets they may establish.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Teva is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
